Rapid response to fifth-line brigatinib plus entrectinib in an ALK-rearranged lung adenocarcinoma with an acquired ETV6-NTRK3 fusion: a case report
ALK重排伴获得性ETV6-NTRK3融合的肺腺癌患者接受五线治疗后,对布加替尼联合恩曲替尼治疗反应迅速:病例报告
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1339511
Li, Dan; Zhu, Yue; Song, Jincheng; Yang, Dafu; Cui, Saiqiong; Liu, Xin; Wang, Le; Zhang, Jiangyan; Pan, Evenki; Dai, Zhaoxia